Teladoc Health Financial Statements (TDOC)
|
|
|
|
Report date
|
|
|
01.03.2021 |
30.09.2021 |
28.02.2022 |
01.03.2023 |
23.02.2024 |
|
31.10.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 094 |
|
2 033 |
2 407 |
2 602 |
|
2 575 |
|
Operating Income, bln rub |
|
|
-418.2 |
|
-239.0 |
13 198 |
-248.6 |
|
-257.8 |
|
EBITDA, bln rub |
? |
|
-438.0 |
|
-84.7 |
-13 383 |
154.0 |
|
-724.5 |
|
Net profit, bln rub |
? |
|
-485.1 |
|
-428.8 |
-13 660 |
-220.4 |
|
-1 035 |
|
|
OCF, bln rub |
? |
|
-53.5 |
|
194.0 |
189.3 |
350.0 |
|
216.7 |
|
CAPEX, bln rub |
? |
|
26.0 |
|
63.9 |
172.8 |
156.3 |
|
123.0 |
|
FCF, bln rub |
? |
|
-79.6 |
|
130.1 |
16.5 |
193.7 |
|
210.9 |
|
Dividend payout, bln rub
|
|
|
0.000 |
|
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
|
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
1 121 |
|
1 621 |
1 890 |
2 091 |
|
1 719 |
|
Cost of production, bln rub |
|
|
390.8 |
|
650.3 |
744.0 |
760.0 |
|
951.3 |
|
R&D, bln rub |
|
|
164.9 |
|
311.9 |
333.6 |
348.5 |
|
311.9 |
|
Interest expenses, bln rub |
|
|
60.5 |
|
80.4 |
9.27 |
22.3 |
|
22.6 |
|
|
Assets, bln rub |
|
|
17 755 |
17 653 |
17 735 |
4 345 |
4 392 |
|
3 529 |
|
Net Assets, bln rub |
? |
|
15 884 |
15 988 |
16 046 |
2 308 |
2 326 |
|
1 508 |
|
Debt, bln rub |
|
|
1 465 |
1 297 |
1 267 |
1 573 |
1 592 |
|
1 589 |
|
Cash, bln rub |
|
|
786.6 |
826.4 |
896.0 |
918.2 |
1 124 |
|
1 244 |
|
Net debt, bln rub |
|
|
678.7 |
470.5 |
371.4 |
655.1 |
468.6 |
|
345.0 |
|
|
Ordinary share price, rub |
|
|
200.0 |
126.8 |
91.8 |
23.7 |
21.6 |
|
34.9 |
|
Number of ordinary shares, mln |
|
|
90.5 |
|
156.9 |
161.5 |
162.2 |
|
170.2 |
|
|
Market cap, bln rub |
|
|
18 098 |
0 |
14 410 |
3 818 |
3 495 |
|
5 941 |
|
EV, bln rub |
? |
|
18 777 |
470 |
14 782 |
4 474 |
3 963 |
|
6 286 |
|
Book value, bln rub |
|
|
-718 |
1 517 |
-369 |
-602 |
-425 |
|
-272 |
|
|
EPS, rub |
? |
|
-5.36 |
|
-2.73 |
-84.6 |
-1.36 |
|
-6.08 |
|
FCF/share, rub |
|
|
-0.88 |
|
0.83 |
0.10 |
1.19 |
|
1.24 |
|
BV/share, rub |
|
|
-7.94 |
|
-2.35 |
-3.73 |
-2.62 |
|
-1.60 |
|
|
EBITDA margin, % |
? |
|
-40.0% |
|
-4.17% |
-556.1% |
5.92% |
|
-28.1% |
|
Net margin, % |
? |
|
-44.3% |
|
-21.1% |
-567.5% |
-8.47% |
|
-40.2% |
|
FCF yield, % |
? |
|
-0.44% |
0.00% |
0.90% |
0.43% |
5.54% |
|
3.55% |
|
ROE, % |
? |
|
-3.05% |
0.00% |
-2.67% |
-591.9% |
-9.47% |
|
-68.6% |
|
ROA, % |
? |
|
-2.73% |
0.00% |
-2.42% |
-314.3% |
-5.02% |
|
-29.3% |
|
|
P/E |
? |
|
-37.3 |
|
-33.6 |
-0.28 |
-15.9 |
|
-5.74 |
|
P/FCF |
|
|
-227.5 |
|
110.8 |
231.0 |
18.0 |
|
28.2 |
|
P/S |
? |
|
16.5 |
|
7.09 |
1.59 |
1.34 |
|
2.31 |
|
P/BV |
? |
|
-25.2 |
0.00 |
-39.1 |
-6.34 |
-8.22 |
|
-21.8 |
|
EV/EBITDA |
? |
|
-42.9 |
|
-174.6 |
-0.33 |
25.7 |
|
-8.68 |
|
Debt/EBITDA |
|
|
-1.55 |
|
-4.39 |
-0.05 |
3.04 |
|
-0.48 |
|
|
R&D/CAPEX, % |
|
|
633.4% |
|
487.8% |
193.1% |
222.9% |
|
253.6% |
|
|
CAPEX/Revenue, % |
|
|
2.38% |
|
3.15% |
7.18% |
6.01% |
|
4.78% |
|
| Teladoc Health shareholders |
